Concepedia

Helen Moore

HM

33

Publications

1.5K

Citations

20

H-Index

1965

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

New South Wales Department of Health

The University of Sydney

Flinders Medical Centre

AstraZeneca (United States)

Helen Moore is an author at Bristol-Myers Squibb (United States) specializing in medicine, public health, and epidemiology.

Top concepts

MedicinePublic HealthHematologyImmunologyEpidemiologyHealthSystems BiologyPathologyEngineeringCell Biology

Publications per year

1965–2022

33

Publications

33

Standard Preanalytical Coding for Biospecimens: Review and Implementation of the Sample PREanalytical Code (SPREC)

Sabine Lehmann, Fiorella Guadagni, Helen Moore et al. · Biopreservation and Biobanking · 2012 · 171 citations · Full text

Engineering, Biomolecular Tool, Verification And Validation +23

A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction

Helen Moore, Natasha K. Li · Journal of Theoretical Biology · 2004 · 154 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +12

Circadian Rhythmicity and Light Sensitivity of the Zebrafish Brain

Helen Moore, David Whitmore · PLoS ONE · 2014 · 110 citations · Full text

Alertness, Neurophysiology, Neuroanatomy +14

Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB)

Yaffa Rubinstein, Stephen C. Groft, Ronald Bartek et al. · Contemporary Clinical Trials · 2010 · 109 citations

Health Informatics, Clinical Data, Biorepository Database +10

Optimal control of treatment in a mathematical model of chronic myelogenous leukemia

Seema Nanda, Helen Moore, Suzanne Lenhart · Mathematical Biosciences · 2007 · 107 citations

Hematological Malignancy, Optimal Control, Mixed-phenotype Acute Leukemia +8

Rows per page

1–5 of 33